Navigation Links
China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
Date:5/18/2009

Stockholders' Equity $ 26,364,737 $ 20,253,041

CHINA DASHENG BIOTECHNOLOGY COMPANY (FORMERLY NAMED AS MAX NUTRITION INC.) CONSOLIDATED STATEMENTS OF OPERATION (Unaudited) FOR THE NINE AND THREE MONTHS

                ENDED MARCH 31, 2009 and 2008 (in US DOLLARS)

                               For the nine months  For the three months ended
                                  ended March 31,              March 31,
                                 2009         2008         2009        2008
    Net Sales              $16,076,862   $ 11,421,215  $ 5,308,553 $ 3,706,091
    Cost of Sales           (8,270,673)    (6,135,328)  (2,665,814) (1,945,490)
    Gross profit             7,806,189      5,285,887    2,642,739   1,760,601
    Operating Expenses:
     Selling expenses          966,504        603,492      316,595     202,689
     General and
     administration expense  1,583,324      1,388,148      758,157     904,209
    Total operating expenses 2,549,828      1,991,640    1,074,752   1,106,898
    Income from Operations   5,256,361      3,294,247    1,567,987     653,703
    Other Income and
     Expenses:
     Interest income
     (expenses)                 83,245        (31,837)      29,653      (3,194)
     Other income                2,925             --           --          --
     Other expenses             (4,363)       (58,468)         646      (1,319)
    Total other income and
     (expense)                  81,807        (90,305)      30,299      (4,513)
    Income before income
     taxes and minority
     interest                5,338,168      3,203,942    1,598,286     649,190
    Minority Interest         (973,579)      (607,097)    (293,613)   (215,623)
    Net income             $ 4,364,589    $ 2,596,845  $ 1,304,673     433,567
    Other Comprehensive
     Income:
       Foreign currency
        translation
        adjustment            (116,464)     1,070,681       31,68
'/>"/>
SOURCE China Dasheng Biotechnology Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 1, 2015 R-Japan Co.,Ltd. obtained the license of ... Regenerative Medicine from the Ministry of Health, Labour and Welfare ... The fact that R- Japan ... auditing from Pharmaceuticals and Medical Devices Agency (PMDA) on May ... to provide stem cell manufacturing service to medical institutions. As ...
(Date:6/30/2015)... , June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... on developing therapeutics that address unmet medical needs ... George Elston will present at the Cantor ... July 8, 2015Time: , 4:45 PM EDTLocation: , ... & archive): , www.juniperpharma.com, under  ,Investor, ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares proposed to be ... (including shares of unvested restricted stock). On June 29, 2015, the last trading day ... shares reported on the OTCBB was $2.29 per share. , The tender offer will ...
(Date:6/30/2015)... NEW YORK , June 30, 2015  The Dr. ... is now offering a full suite of new ... who,ve had a biopsy, for diagnosing prostate cancer. ... a range of genetic tests for assessing the risk and ... "We,re very excited to now offer these ...
Breaking Biology Technology:R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 2New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 3New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 4New Revolutionary Genetic Testing for Prostate Cancer Offered at Dr. Samadi's Prostate Cancer Center 5
... Dendreon Corporation today announced that Chief Executive Officer, Mitchell ... & Young Entrepreneur Of The Year (R) 2009 ... & Young LLP, the awards program recognizes entrepreneurs who ... performance and personal commitment to their businesses and communities. ...
... /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS;,Nasdaq: PXSL ) ... Food and Drug Administration (FDA) that the New Drug ... been accepted for,standard review. The FDA will advise ... Pharmaxis is seeking approval for ...
... DIEGO, May 13 Dr. Feng Lin, Director of ... BMSN) and Entest BioMedical Inc., today stated that he ... injury" (TBI) using autologous "adipose-derived" stem cells represents a ... both Bio-Matrix and Entest BioMedical are now studying the ...
Cached Biology Technology:Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest 2U.S. FDA Accepts Aridol(TM) New Drug Application for Review 2'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher 2
(Date:6/16/2015)... 2015 /CNW Telbec/ - handyem Inc. and FlowMetric ... incorporation of handyem,s HPC-150 portable flow cytometer within ... This unprecedented model of mobile laboratory platform is ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue ...
(Date:6/15/2015)... , June 15, 2015 A ... from Telstra reveals the majority of US consumers using mobile ... via biometrics, such as fingerprint and voiceprint, instead of having ... According to Telstra,s " Mobile Identity   -   ... report, with smartphones now the primary channel used by ...
(Date:6/9/2015)... June 9, 2015   MedNet Solutions , an ... spectrum of clinical research, will be providing demonstrations of ... at the 2015 Drug Information Association (DIA) Annual Meeting ... 15-17.  These presentations will include previews of many exciting ... the upcoming iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
... avoid cancer of the kidneys, a new major study from ... kinds of fatty fish a few times a month would ... the end of the 1980s, 90,000 Swedish women were sent ... mammography scan. Now, with the help of another questionnaire a ...
... dramatic increase in testicular cancer, now the most ... the focus of a five-year, $5.5 million National ... researcher Tongzhang Zheng. , Testicular cancer is increasing ... important information on possible environmental, genetic and other ...
... have discovered a new, more accurate, method of mapping ... could lead to more effective treatments and prevention of ... Duncan Maskell at the Centre for Veterinary Science, and ... with observational data to predict the spread of individual ...
Cached Biology News:Researchers map spread of pathogens in the human body 2
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Rabbit polyclonal to FANCG ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSRQTTSVGSSC, corresponding to amino acids 1 - 12 of Human FANCG. Entrez GeneID: 2189 Swis...
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6...
...
Biology Products: